Trials / Completed
CompletedNCT01155089
Bioequivalency Study of Anastrozole 1 mg Under Fed Conditions
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Anastrozole 1 mg Tablets Under Fed Conditions
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Roxane Laboratories · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study was to prove the bioequivalence of Anastrozole Tablet under fed conditions
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Anastrozole | 1 mg tablet |
Timeline
- Start date
- 2006-05-01
- Primary completion
- 2006-06-01
- Completion
- 2006-06-01
- First posted
- 2010-07-01
- Last updated
- 2018-01-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01155089. Inclusion in this directory is not an endorsement.